SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-24-000031
Filing Date
2024-08-01
Accepted
2024-08-01 16:40:37
Documents
96
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tvtx-20240630.htm   iXBRL 10-Q 1721649
2 EX-31.1 tvtx-06302024x10qxex311.htm EX-31.1 12712
3 EX-31.2 tvtx-06302024x10qxex312.htm EX-31.2 12410
4 EX-32.1 tvtx-06302024x10qxex321.htm EX-32.1 8769
5 EX-32.2 tvtx-06302024x10qxex322.htm EX-32.2 8849
11 GRAPHIC tvtx-20240630_g1.jpg GRAPHIC 54254
  Complete submission text file 0001438533-24-000031.txt   9387392

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvtx-20240630.xsd EX-101.SCH 62146
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tvtx-20240630_cal.xml EX-101.CAL 105147
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvtx-20240630_def.xml EX-101.DEF 377951
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvtx-20240630_lab.xml EX-101.LAB 761153
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvtx-20240630_pre.xml EX-101.PRE 584152
99 EXTRACTED XBRL INSTANCE DOCUMENT tvtx-20240630_htm.xml XML 1245554
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 241167408
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)